Navigation Links
Breakthrough HIV Technology Could Revolutionize Patient Care in Zimbabwe
Date:2/9/2013

Waltham, Massachusetts (PRWEB) February 09, 2013

Alere Inc. is pleased to announce that, with the aid of a revolutionary point-of-care device, World Health Clinicians, a US-based nongovernmental organization, were able to provide absolute CD4 counts for patients living with HIV in rural Zimbabwe in under 20 minutes. This outcome is the result of a proof-of-concept evaluation World Health Clinicians performed in conjunction with the Zimbabwean Ministry of Health. Zimbabwe has a population of approximately 11.6 million people, 1.2 million of whom are infected with HIV.

In HIV-infected individuals, total CD4 count is the most robust surrogate marker for immune competence, identifying when patients need to start life-saving, antiretroviral therapy. As part of its evaluation, the World Health Clinicians team ran rapid HIV screening tests as well as total CD4 cell counts, providing a complete set of results in less than one hour, a service that is currently unavailable in even the most developed parts of the world. More information about the evaluation and its results can be found by accessing the link below.

VIDEO    http://alerehiv.com/video/alere-pima-cd4-in-zimbabwe/

Designed and engineered in Germany, the Alere Pima™ CD4 test provides an accurate, absolute CD4 count using a small amount of blood drawn from a fingerstick. The analyzer weighs 2.5kg (5.5lbs) and runs on either battery or A/C power, allowing for easy transport and use in even the most remote and challenging environments.

In particular, the Alere Pima™ CD4 test enabled the team from World Health Clinicians to conduct house-to-house CD4 testing outside the clinic, reaching patients who would otherwise go without results. Moreover, when the clinic lost power for 3 ½ hours, a common occurrence in the region, the team was able to switch to battery-operated power and continue CD4 testing.

“I think this is one of the most practical systems I’ve ever seen–for the fact that it’s so lightweight, it lasts so long with the back-up battery, and it takes twenty minutes and a single fingerstick to run,” said Dr Gary Blick, CEO of World Health Clinicians. “I would love to have access to this in the United States.”

Alere, a leading provider of near-patient diagnostics, is committed to developing solutions that support the screening and monitoring of people living with HIV. The company manufactures a range of point-of-care diagnostics for HIV screening, monitoring and the detection of such co-morbidities as tuberculosis, including the Alere Determine™ HIV-1/2 and the Alere Determine™ TB LAM Ag tests.

For more information about Alere’s diagnostic tools for chronic HIV management, go to http://www.AlereHIV.com.

About Alere
By developing new capabilities in near-patient diagnosis, monitoring and health information technology, Alere enables individuals to take charge of improving their health and quality of life at home. Alere's global leading products and services, as well as its new product development efforts, focus on cardiology, infectious disease, toxicology and diabetes. Alere is headquartered in Waltham, Massachusetts. For more information regarding Alere, please visit http://www.alere.com.

Read the full story at http://www.prweb.com/releases/2013/2/prweb10411079.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Bascom Palmer Eye Institute announces breakthrough for degenerative vision disorder
2. Scientists make breakthrough in bile duct cancer with discovery of new gene mutations
3. An important breakthrough in immunology by IRCM researchers
4. Ear, Nose & Throat Journal publishes research on breakthrough treatment for tonsil stones
5. Trivedi Beef, LLC Announces Breakthrough Beef Industry Data without the use of Antibiotic Drugs, Hormones or Steroids
6. Breakthrough Brings Transparency to Male/Female Relationships
7. Breakthrough treatment reduces post-surgical scarring for glaucoma patients
8. Research breakthrough could halt melanoma metastasis
9. Breakthrough nanoparticle halts multiple sclerosis
10. Nanomedicine breakthrough could improve chemotherapy for childhood cancer
11. Western University researchers make breakthrough in arthritis research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... FL (PRWEB) , ... February 17, 2017 , ... ... software tools that allow for the electronic prescribing of controlled and non-controlled substances ... , Ninety percent of pharmacies in the United States now accept electronic prescriptions, ...
(Date:2/17/2017)... ... February 17, 2017 , ... Empowering each person's mental functions, ... each and every seminar, session and class she offers. At the International ... which help energize creativity, focus mental functions, enhance athletic focus and skill sets, ...
(Date:2/17/2017)... , ... February 17, 2017 , ... ... the HIMSS17 Conference & Exhibition in Orlando, Fla., February 19-23. Visitors to the ... the most widely used electronic patient signatures solution in healthcare . ...
(Date:2/17/2017)... ... February 17, 2017 , ... Pharmica Consulting attended ... all facets of clinical trial planning and management. Pharmica discussed the importance of ... In addition, attendees stopping by Pharmica’s booth were able to demo its cloud-based ...
(Date:2/17/2017)... ... 17, 2017 , ... Like most hospitals across the nation, Onslow Memorial Hospital ... the Hospital Readmission Reduction Program (HRRP), the return of a patient to the hospital ... the nation. While many providers are struggling to leverage limited resources and technology, Onslow ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... Cryoablation, Electrical, Endometrial Hydrothermal, Laser/Light, Microwave, Radiofrequency, Ultrasound, Cardiovascular, Gynaecology, ... expected to grow at a CAGR of 9.4% from 2017-2022 and ... at a CAGR of 9.5% from 2017 to 2027. The market ... ... benefit you Read on to discover how you can exploit ...
(Date:2/17/2017)... 2017 Arvinas LLC, a private biotechnology company ... degradation, today announced the presentation of new preclinical data ... poster session at the American Society of Clinical Oncology ... Orlando, FL. "The new ... the potential of PROTACs to drive durable and robust ...
(Date:2/17/2017)... and Markets has announced the addition of the "Pharmaceutical Contract Manufacturing ... ... the US, Canada , Japan , ... of World. Annual estimates and forecasts are provided for the period 2015 ... Market data and analytics are derived from primary and secondary research. ...
Breaking Medicine Technology: